Dr. Srikala Sridhar

Dr. Srikala Sridhar holds the position of Professor in the Department of Medicine at the University of Toronto, and is a Genitourinary Medical Oncologist and Site Lead at the Princess Margaret Cancer Center. She is chair of the Genitourinary Medical Oncologists of Canada and Vice Chair of the Medical Advisory Board of Bladder Cancer Canada. Additionally, she contributes her expertise as a member of the Canadian Clinical Trials Group – Genitourinary Disease Site Executive Committee, and the US National Cancer Institute Bladder Cancer Task Force. Her primary research focus lies in new drug development and Phase II clinical trials. She has significantly impacted the field of genitourinary oncology through her involvement as a principal or co-investigator on numerous industry and investigator initiated clinical trials, including several practice changing trials. With a specialization in advanced urothelial cancers, she is recognized internationally for her expertise. Her recent contributions to the field can be found in the New England Journal of Medicine, JAMA Oncology, and European Urology.
In recognition of her dedication and excellence in teaching and mentorship, Dr. Sridhar was honored with the University of Toronto, Department of Medicine, Postgraduate Medicine Teaching Award in 2011 and the Robert Hyland Mentorship Award in 2020.